The 7.5mg and 12.5mg intermediate doses were included in clinical protocols as transitional steps to improve tolerability but were not separate study arms in SURMOUNT-1
Again, a biomarker would be an ideal outcome measure, if it would measure the presence of IC/BPS and changes in the biomarker would reflect a response to treatment
Dempsey suggested it may be reducing neuroinflammation
Novo Nordisk may modify or discontinue the program at any time
Wang J, Liu Y-T, Xiao L, Zhu L, Wang Q, Yan T
These two varieties were grown in pots of a rain shelter open field of Bangabandhu Sheikh Mujibur Rahman Agricultural University, Bangladesh (AEZ-28, 2423 north latitude, 9008 east longitudes, 8.4 m.s.l.)